NCT07429721: A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019A in Patients With Relapsed/Refractory Multiple Myeloma.

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Phase: EARLY_PHASE1. Conditions: Multiple Myeloma (MM)